Showing results (81-90 of 103) with videos related to
Sort By:
Pageof 11
Cancer Letters|November 19, 2025
Manganese mediates nucleoplasm distribution of cGAS to enhance systemic antitumor immunity and drive abscopal effectTiance Wang, Zijian Lv, Runjia Fan, et al.Cancer Medicine|July 6, 2023
Clinical features and prognosis of patients with metastatic ocular and orbital melanoma: A bi-institutional studyXin Liu, Han Yue, Shiyu Jiang, et al.Future Oncology (London, England)|May 5, 2018
Systematic review on the efficacy and safety of immune checkpoint inhibition in renal cell carcinomaChen Lyu, Wenyue Li, Songcai Liu, et al.Journal for Immunotherapy of Cancer|April 6, 2021
Improved clinical outcome in a randomized phase II study of anti-PD-1 camrelizumab plus decitabine in relapsed/refractory Hodgkin lymphomaYang Liu, Chunmeng Wang, Xiang Li, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 6, 2021
Efficacy of Decitabine plus Anti-PD-1 Camrelizumab in Patients with Hodgkin Lymphoma Who Progressed or Relapsed after PD-1 Blockade MonotherapyChunmeng Wang, Yang Liu, Liang Dong, et al.Plant Biotechnology Journal|December 2, 2023
PbHsfC1a-coordinates ABA biosynthesis and H2O2 signalling pathways to improve drought tolerance in Pyrus betulaefoliaFeng Zhang, Chunmeng Wang, Jia-Long Yao, et al.Signal Transduction and Targeted Therapy|July 31, 2020
The model of cytokine release syndrome in CAR T-cell treatment for B-cell non-Hodgkin lymphomaJianshu Wei, Yang Liu, Chunmeng Wang, et al.Redox Biology|April 23, 2023
UTP11 deficiency suppresses cancer development via nucleolar stress and ferroptosisYu Gan, Jun Deng, Qian Hao, et al.Journal of Hematology & Oncology|April 5, 2020
Bispecific CAR-T cells targeting both CD19 and CD22 for therapy of adults with relapsed or refractory B cell acute lymphoblastic leukemiaHanren Dai, Zhiqiang Wu, Hejin Jia, et al.Blood|June 20, 2020
Optimized tandem CD19/CD20 CAR-engineered T cells in refractory/relapsed B-cell lymphomaChuan Tong, Yajing Zhang, Yang Liu, et al.Pageof 11